JTP-27536

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameJTP-27536

Drug Alias Nameimmunoglobulin/interleukin-5 inhibitor (Japan Tobacco)JTP-27536

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-5 receptors inhibitorsImmunoglobulin inhibitors

TargetsInterleukin-5 receptorsImmunoglobulin

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJapan Tobacco Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesJapan Tobacco Inc

Active IndicationsN/A

Inactive IndicationsHypersensitivity

ATC CodeN/A